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Two pantothenate-requiring mutants of Agrobacterium tumefaciens have
been isolated. One of them (strain WMP-1) is unusual in that growth levels
equivalent to the parent strain are achieved only when the medium is
additionally supplemented with aspartate or another compound related to the
tricarboxylic acid cycle. Extracts of cells grown on limiting aspartate were found
to contain four times more "IC-pantothenate than th6se grown at optimal
aspartate concentrations. This difference was found in both the
perchloric acid-soluble and -insoluble fractions, presumably the coenzyme A
pool and acyl carrier protein, respectively. These findings are discussed in terms
of membrane integrity and the control of fatty acid biosynthesis.
Most of the pantothenate taken up by mi-
croorganisms is converted to coenzyme A (24,
25). Pantothenate and coenzyme A deficiencies
manifest themselves in a wide variety of ways,
but Guirard and Snell (8) concluded that these
are all compatible with the sole role of coen-
zyme A as the carrier and activator of acetyl
and other acyl groups. As an example, Holden
et al. (11, 12) observed pantothenate deficien-
cies to be accompanied by a decreased ability
to accumulate glutamate and other amino
acids. Significantly, this was not due to defec-
tive uptake mechanisms but to a leakiness in
the membrane that prevented the maintenance
of the amino acid pools once formed. This
defect could be corrected by the addition of
exogenous fatty acids (10). Their interpretation
is reasonable in view of the findings of Vagelos
and co-workers (1, 6, 26) that coenzyme A is the
immediate precursor of the 4'-phosphopante-
theine moiety of the fatty acid synthetase acyl
carrier protein.
Nutritional interdependency is well known
(8). Vitamin requirements may be met by the
addition of either the vitamin itself or the
various end products of the metabolic reactions
for which the vitamin was needed. The replace-
ment of biotin by exogenous aspartate and
fatty acids has been well studied (3). For those
vitamins involved in fatty acid, and thus mem-
' Postdoctoral Research Associate.
'Present address: Department of Health Sciences, Grand
Valley State College, Allendale, Mich. 49401.
brane, biosynthesis (i.e., biotin and pantothe-
nate), apparent vitamin and amino acid nutri-
tional requirements may be related only secon-
darily. Membrane defects may change permea-
bility and pool size, as well as the functioning
of membrane-bound proteins such as the per-
meases.
The addition of free fatty acids can eliminate
80% of the pantothenate requirement in Strep-
totoccus faecalis (29) and correct the glutamate
pool deficiency in Lactobacillus plantarum
(10). We want to know whether these inter-
dependent effects of pantothenate deficiency
are true of other bacteria, particularly those
whose membrane fatty acid and phospholipid
compositions are atypical. Agrobacterium
tumefaciens was the organism of choice be-
cause it is known (5, 15) to contain methylated
phospholipids such as phosphatidyl choline
that are not present in the vast majority of
bacteria (19). We have previously used this
microorganism to study the unique membrane
lipid methylations yielding phosphatidyl cho-
line (14) and the cyclopropane fatty acids (13).
Preliminary experiments indicated that pan-
tothenate metabolism in A. tumefaciens strain
WMP-1 was influenced by the pool size of
compounds related to the tricarboxylic acid
cycle in a manner exactly opposite to what one
would expect if aspartate were acting solely as
the precursor of the ,8-alanine moiety of pan-
tothenate. An understanding of this relation
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control of fatty acid synthesis and the rate of
pantothenate utilization.
Carbohydrate metabolism in A. tumefaciens
has been characterized by radiorespirometry
(L. Arthur, G. St. Julian, and L. Bulla, unpub-
lished data). Functional pentose phosphate,
Entner-Doudoroff, and tricarboxylic acid cy-
cles are present to the exclusion of the Emb-
den-Meyerhof-Parnas path. The absence of
glycolysis is another variable that conceivably
could alter the pantothenate metabolism.
MATERIALS AND METHODS
Strains used. A. tumefaciens WP-3 (NRRL
B-3738) is a pantothenate-requiring mutant derived
from the wild-type strain W (NRRL B-36); strain
WMP-1 (NRRL B-3737B) is a mutant requiring both
methionine and pantothenate that is derived from
the methionine-requiring strain WM-11 (NRRL
B-3557), which itself had been previously (13) de-
rived from strain W also. The pantothenate-requiring
mutants were isolated by a procedure in which
N-methyl-N'-nitro-N-nitrosoguanidine (300 ug/ml)
was used as the mutagen, followed by enrichment in
media (13) supplemented with 2 ug of calcium
pantothenate/ml. Mutant growth in response to ex-
ogenous pantothenate and amino acids was deter-
mined turbidimetrically (Klett no. 66 filter), after
aerobic incubation at 25 C. When strain WMP-1 is
grown in basal medium (BM; 13) supplemented with
methionine, pantothenate, and aspartate, 250 Klett
units is found to equal 1.0 mg (dry weight) of cells per
ml.
Nutritional characterization. Inocula for all
subsequent experiments were grown for 24 to 48 hr on
yeast extract-nutrient agar slants. A loopful of cells
was suspended in saline for 0.5 hr, and 0.2 ml was
inoculated into 25 ml of BM with the appropriate
supplement. Growth response to added nutrients was
determined from the turbidity ratio of supplemented
and unsupplemented cultures after incubation times
varying from 20 to 35 hr. When 0.2 ml of the WMP-1
saline suspension was plated on BM with methio-
nine, no pantothenate-independent colonies were
detected after 3 days.
Most of the following pool size and pantothenate
uptake experiments were done with strain WMP-1;
500-ml cultures were grown aerobically in Fernbach
flasks. After their turbidities were determined, all of
the cultures were harvested at the same time. Since
the doubling time is known to increase as the supply
of methionine or aspartate decreases, this means our
cultures are not at precisely the same stage of growth.
All cells were centrifuged before the fastest growing
culture (BM with 75 Mg of methionine, 150 gg of
L-aspartate, and 4 Mg of calcium pantothenate/ml)
entered the stationary phase. Our subsequenb experi-
ments on pantothenate uptake and accumulation
compare cells from amino acid-limited cultures in
early exponential phase with cells from cultures with
optimal amounts of the same amino acid and in late
exponential phase. Since both cultures are still
exponential, not many cyclopropane fatty acids
would be expected to have been formed yet (18).
Accumulation of pantothenate. Cells were har-
vested after 20 to 35 hr of growth and suspended in
0.01 M potassium phosphate buffer atpH 7.0 contain-
ing 0.01 M 2-mercaptoethanol (1). Cytoplasmic ex-
tracts were obtained by breaking the cells in a French
press, whereupon the cellular residue was centrifuged
at 22,000 x g for 30 min. Estimation of viable count
indicated that about 80% of the WMP-1 cells were
ruptured, independent of whether they had been
grown on optimal or limiting aspartate. This finding
eliminates the possibility that our observed differ-
ences in pantothenate accumulation are really due to
a differential degree of cell rupture.
The pantothenate concentrations in the cytoplas-
mic extracts, expressed as nanomoles per milligram
of protein, were determined in two ways. (i) Coen-
zyme A was determined from its concentration effect
on phosphotransacetylase catalysis in the presence of
excess acetyl phosphate (1). This indirect method is
valid because most of the added pantothenate is
converted to coenzyme A. (ii) Pantothenate accumu-
lation was measured directly by growing the cells in
media to which 1.60 Mmoles of "4C-pantothenate (0.84
Ci/mole) had been added. These cytoplasmic ex-
tracts were adjusted to contain identical amounts of
protein, whereupon they were treated with 1 M HClO4
(1). The amounts of "4C-pantothenate in the cyto-
plasmic extracts and aqueous suspensions of the
acid-insoluble fractions were determined. The per-
chloric acid-soluble fraction is presumed to represent
the joint pool of pantothenate and coenzyme A,
whereas all protein-bound pantothenate, particularly
the acyl carrier protein of fatty acid synthetase,
would be perchloric acid insoluble.
Protein concentrations were determined by the
method of Lowry et al. (20).
Uptake of pantothenate. WMP-1 cells grown
under aspartate-limiting conditions were harvested,
washed, adjusted to a final turbidity of 200 Klett
units, and equilibrated for 15 min in media (13)
either containing or not containing 4 Mg of aspartate/
ml at 25 C. The procedure of Britten and McClure (2)
was modified to measure "4C-pantothenate uptake
and pool formation. "4C-pantothenate (final concen-
tration, 5.7 x 10-7 M) was added to 20 ml of the cell
suspensions, and samples were taken at intervals to
determine the amount of "4C-pantothenate that was
taken up into either whole cells or trichloroacetic
acid-insoluble material. Membrane filters (0.45 Am
pore size) were used to collect the samples, and the
pool size was determined by subtracting the tri-
chloroacetic-insoluble "4C-pantothenate from that of
whole cells. Since these experiments were conducted
at 25 C rather than at 0 C, we are not measuring the
size of a preexisting pool by exchange, but, instead,
are comparing the ability to form a pantothenate
pool and the maximum such a pool can achieve at a
given exogenous pantothenate concentration.
Radioactivity measurements. D-Pantothenic-
1,3-"4C acid was obtained from International Chem-
ical & Nuclear Corp. Radioactivity was deter-




























PANTOTHENATE ACCUMULATION IN A. TUMEFACIENS
with corrections for dilution, quenching, and back-
ground. Samples containing water were counted
in a dioxane solution (18); all others were made in
toluene containing 4 g of 2,5-diphenyloxazole and 50
mg of 1, 4-bis [2-(4-methyl-5-phenyloxazolyl) I ben-
zene per liter.
RESULTS
Mutant growth requirements. Exogenous
pantothenate was found to be required for the
growth of mutant strains WP-3 and WMP-1 in
BM containing optimal methionine (75 jig/ml).
The parent strains W and WM-11 do not
require pantothenate. Either 0.4 jig of calcium
pantothenate or 5 ug of DL-pantoyl lactone per
ml satisfied the pantothenate requirement.
The fact that pantoyl lactone could replace
pantothenate immediately classifies our mu-
tants as defective in the synthesis of pantoic
acid rather than the other component of pan-
tothenate, namely, 0-alanine. The greater re-
quirement for DL-pantoyl lactone is consistent
with Novelli's (23) observation that pantothe-
nate synthetase is specific for L-pantoic acid,
and thus preliminary hydrolysis of the lactone
is required.
Strain WP-3 appears to be a normal vitamin
auxotroph in that added pantothenate restored
growth to parental levels. The situation with
WMP-1 is more complex, however. Parental
growth levels could be achieved only when the
pantothenate or pantoyl lactone was supple-
mented by the addition of aspartate (Fig. 1) or
another compound related to the tricarboxylic
acid cycle (Table 1). Figure 1 shows that
maximal growth required the addition of me-
thionine, pantothenate, and aspartate to the
basal medium. Omission of any one prevented
growth. Those cultures that did grow in the
absence of either aspartate or pantothenate did
so after long lag periods and were found to be
revertants. The revertants were uniformly in-
dependent of exogenous pantothenate. Note
that the absence of aspartate has selected for
strains that no longer require pantothenate,
even though pantothenate was present in the
medium which contained no aspartate. This re-
sult indicates that the double requirement re-
sults from a pleiotropic mutation rather than a
fortuitous double mutation.
Strain WMP-1 is indeed a pantothenate
mutant because: (i) when pantothenate was
omitted no growth was observed; (ii) no other
compound has yet been found to substitute for
pantothenate; (iii) in the absence of exogenous
aspartate the addition of pantothenate beyond
those amounts required by a typical pantothe-
nate auxotroph such as strain WP-3 was with-
u x 20 30 40 50
Incubation Time (Hr.)
FIG. 1. Growth of strain WMP-1 aerobically at 25
C in response to external nutrients. The control
medium (A) contained a complete supplement of
methionine (75 jg of Met/ml), calcium pantothenate
(4 jg of Pa/mI), and aspartic acid (150 Ag of Asp/ml)
in a basal medium. (x) Pa and Asp are missing; (0)
Met is missing; (@) Pa is missing; (A) Asp is missing.
TABLE 1. Growth stimulation in Agrobacterium
tumefaciens by tricarboxylic acid cycle-related
compounds
Klett.. turbidity
Supplement (300 jig/ml)a ratiob of strains
WM-11 WP-3 WMP-1
None (control)b ........... 1.0 1.0 1.0
L-Aspartic acid ........... 2.3 1.7 5.5
Succinic acid ............. 2.4 1.0 5.0
Fumaric acid ............. 2.1 1.3 4.1
Malic acid ................ 2.2 0.3 2.4




aAll media neutralized with KOH to pH 6.8.
' Growth stimulation was recorded by Klett., tur-
bidity ratios (no. 66 filter) of supplemented cultures
to an unsupplemented control. WM-11 control = 38
Klett,. units after 24 hr; WP-3 = 30 after 30 hr;
WMP-1 = 9 after 30 hr. All controls contained
pantoyl lactone (20 jzg/ml) and methionine (100
jig/ml) in basal medium at 25 C.
c L-Glutamic acid (150 Mg/ml of medium) and 4 ,g
of calcium pantothenate in place'of pantoyl lactone.
The cultures were incubated for approximately 35 hr.
Growth stimulation with aspartate in place of gluta-
mate was 13.7 in this experiment.
d ,-Alanine (120 ug/ml), incubated for 44 hr.
e Biotin (0.8 Ag/ml), incubated for 24 hr.
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FIG. 2. Growth response of strain WMP-1 (Agrobacterium tumefaciens mutant) to exogenous L-aspartate
(A) and L-methionine (B) in a basal medium (BM) containing DL-pantoyl lactone (20 Mg/ml used in place of
pantothenate). The culture of curve A contained excess methionine (75 gg/ml) and that of curve B contained
excess aspartate (120 Mg/ml) as supplements also. All cultures were grown aerobically at 30 C for either 48 hr
(A) or 20 hr (B).
out effect; (iv) in the absence of exogenous
pantothenate intracellular coenzyme A levels
were observed to decrease dramatically in both
of our presumed pantothenate auxotrophs (see
Table 3).
In an effort to understand why strain WMP-1
required aspartate, a variety of compounds
related to aspartate metabolism were tested for
their ability to substitute for aspartate. These
are listed in Table 1. The relative stimulation
by tricarboxylic acid cycle-related compounds
was much greater for strain WMP-1 than for
WM-11 or WP-3, but this was only because the
unsupplemented WMP-1 control did not grow
at all whereas the other two did. The addition
of tricarboxylic acid cycle-related compounds
served to raise the growth of WMP-1 to the
approximate level of the other strains.
Because aspartate is the metabolic precursor
of ,B-alanine, it is important to note that
d-alanine was without effect. This reinforces
our conclusion that the effects observed in
Table 1 represent a general requirement for
tricarboxylic acid cycle intermediates rather
than for the pantothenate precursor, ,B-alanine.
Guirard and Snell (8) concluded that a
typical aspartate auxotroph required only 10 Ag
of aspartate/ml to achieve maximal growth.
Figure 2B shows that the methionine require-
ment in strain WMP-1 appears normal in that
less than 50 ug/ml was required for maximal
growth. The aspartate requirement (Fig. 2A)
was more extensive; 100 to 150 ,g of aspartate/
ml was required, depending on the temperature
chosen. We consider a dependency of this
magnitude to be consistent with the need to
maintain a pool of tricarboxylic acid cycle
intermediates in the presence of a leaky mem-
brane (10-12). The inhibition evident (Fig. 2B)
at high concentrations of methionine may be
due to false feedback inhibition by methionine
on earlier metabolic reactions common to other
end products derived from aspartate (28). An
identical methionine inhibition of growth was
shown by the methionine-independent strain
W. For reasons that are not entirely clear, this
methionine inhibition was not present in the
methionine-dependent strain WM-11, the in-
termediary derived from strain W and from
which WMP-1 was isolated (13).
Pantothenate accumulation. "4C-pantothe-
nate accumulation was evaluated by compari-
son of extracts of cells from 1-day-old cultures
grown under nutritionally complete conditions
with those of cells whose growth had been
limited by suboptimal concentrations of aspar-
tate. Total radioactive counts were measured
both in the whole extract and in the perchloric
acid-insoluble fraction. This latter fraction
consists primarily of the fatty acid synthetase
acyl carrier protein (1), whereas the pantothe-
nate and coenzyme A pools are perchloric
acid-soluble. We thought that information on
total pantothenate accumulation and its in-
tracellular distribution at both limiting and
optimal aspartate concentrations might reveal
why the WMP-1 strain required them both.
Table 2 shows that, when aspartate was
limiting, strain WMP-1 accumulated approxi-
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TABLE 2. 14C-pantothenate accumulation by strain
WMP-I
"'C-pantothenate (nmoles
Cul- per mg of protein)0
Limiting tural
supplementa Strain tur- Cyto- Per- Per-
bidity lasmi chloric chloric
(Klett,,) petract acid precip- acidetatitate soluble
Excess (con-
trol) WM- 11 284 1.36 0.65 0.71
Excess (con-
trol) WP-3 135 2.80 1.89 0.91
Excess (con-
trol) WMP lc 236 1.84 1.12 0.72
Asp-lim WMP lc 28 8.28 4.35 3.93
aMedium supplements are as described in Table
3. All cultures contained an excess of "4C-pantothe-
nate (1.60 umoles or 2.98 x 10. disintegrations per
mm per 500 ml of medium).
b 14C-pantothenate (nanomoles) per milliliter was
determined by dividing the total radioactivity in the
HCl04-precipitate from 1 ml of cytoplasmic extract
by the specific activity (disintegrations per minute
divided by nanomoles of '4C-pantothenic acid). Pro-
tein concentrations are the total protein in 1 ml of
cytoplasmic extract.
cThe turbidity of WMP-1 cultures was measured
after 30 hr of incubation, when the cells were col-
lected by centrifugation.
when it was present in optimal amounts. This
difference was observed in both the perchloric
acid-soluble and -insoluble fractions.
These observations are reinforced by a simi-
lar set of experiments (Table 3) which differed
from those-in Table 2 only in that nonradioac-
tive pantothenate was added initially and the
cell extracts were assayed for coenzyme A
enzymatically. Here too, we see that the coen-
zyme A pool, and thus the amount of pantothe-
nate accumulated, was markedly higher in
strain WMP-1 when its rate of growth had been
limited by deficient levels of aspartic acid or
methionine. It is comforting to note that the
internal control of pantothenate-limited
growth does indeed give negligible coenzyme A
concentrations.
This interdependence of coenzyme A level
with growth condition seems to apply only to
WMP-1. Coenzyme A levels in both the me-
thionine auxotroph WM-1 1 and the pantothen-
ate auxotroph WP-3 remained unchanged in the
various media, even though they consistently
differed from each other by a factor of five. Two
separate methods of assay agreed in indicating
that strain WMP-1 accumulates exogenous
pantothenate to a greater extent if its growth is
TION IN A. TUMEFACIENS 623
TABLE 3. Coenzyme A pool in cytoplasmic extracts
under growth-limiting conditions
Limiting supplementa
Exogenous Strain -__ __
requirement Con- Pa- Met- Asp-
trol lrn lrn lrn
Met WM-11 1.6° 1.9 1.9
Pa WP-3 0.3 0.OC 0.2 0.4
Pa-Met-Asp WMP-ld 0.9 0.2 1.6 1.8
aControl cultures contained an excess of all three
supplements: pantothenate (4 Mg/ml), methionine (75
ug/ml), and aspartic acid (150 Mg/ml). Limiting
supplements of growth medium (1 ml) were as
follows: 0.12 Mg of calcium pantothenate (Pa-lim), 10
Mg of L-methionine (Met-lim), and 9 ,g of L-aspartic
acid (Asp-lim). The cytoplasmic extracts were ob-
tained by French pressure disruption of cells grown
aerobically for approximately 24 hr.
b Nanomoles of coenzyme A per milligram of
cytoplasmic protein.
c No coenzyme A was detected in WP-3 cells (3.2
mg of cytoplasmic protein per ml) if exogenous
pantothenate limited growth.
d The values shown are the mean of two separate
experiments with strain WMP-1.
2 4
_16 / Total
12 TCA Precipitate -
.-......-.....-.-.-.-....a ..@ 8 ,8 - ,, ,S,t,,,,,,fi,,,,~~~~~~~~~.Z..,,,,,,"..."......................... . ....
' g41Tl-----_-__ --_-- CA Soluble- -- - -- -- 0
2 4 6 8 10 15 20
Time (min)
30 45
FIG. 3. Effect of exogenous aspartate on 14C-pan-
tothenate (5.7 x 10-' M) uptake by whole cells
(0, O), trichloroacetic acid-soluble pool (U,
0), and trichloroacetic acid-precipitated materials
(A, A). Strain WMP-1 was grown under an aspar-
tate-limiting condition (see Table 3, Asp-lim). The
washed cells (0.8 mg of dry cells/ml) were prein-
cubated for 15 min either with 4 Mg of aspartate/mI
(closed symbols) or without aspartate (open symbols)
in the basal medium containing 75 gg of methionine/
ml. The soluble pool size (U, 0) was determined by
subtracting the uptakes of trichloroacetic acid-
insoluble material from whole cells.
aspartate limited. We have not conducted sim-
ilar experiments under a sufficient number of
nutritional conditions to state whether these
differences are specific for tricarboxylic acid
cycle components or whether they derive from
general considerations regarding differences in
growth rate and stage of growth. In any case,



























KANESHIRO, ARTHUR, AND NICKERSON
of fatty acid synthesis control mechanisms.
Pantothenate uptake. The fact that aspar-
tate concentrations can influence overall pan-
tothenate accumulation in strain WMP-1 could
mean that it was influencing the cells' ability
either for uptake or for retention once taken up
(10-12). Figure 3 shows a comparison of strain
WMP-1 short-term uptake ability for pan-
tothenate in the presence and absence of exoge-
nous aspartate. The cells had been grown on
limiting aspartate previous to harvesting for
the uptake experiment. In either case, '4C-pan-
tothenate was taken up rapidly and achieved
maximal concentration in the soluble pool
within 7 to 8 min. Thereafter, the "IC-pan-
tothenate pool decreased as it was incorporated
in trichloroacetic acid-insoluble material. This
too occurred at the same rate, regardless of
aspartate concentration.
DISCUSSION
We have shown that A. tumefaciens strain
WMP-1 requires both pantothenate and a tri-
carboxylic acid cycle-related compound for
growth. The biochemical nature of this inter-
dependency is of immediate interest. This
difference between strain WMP-1 and other
pantothenate auxotrophs may be caused by the
genetic location of the pantothenate lesion or
by the simultaneous presence of the methio-
nine auxotrophy. A similar dependence of pan-
tothenate function on sufficient tricarboxylic
acid cycle intermediates has been found for
naturally occurring strains of Erwinia (7) and
Bacillus thuringiensis (K. W. Nickerson, un-
published data).
The primary metabolic role of pantothenate
is to act as a precursor for coenzyme A synthe-
sis. Since exogenous free fatty acids can replace
80% of an organism's nutritional requirement
for pantothenate (29), we thought it reasonable
to examine the unique features of strain
WMP-1 with a view toward possible fatty acid
biosynthetic controls. That such controls exist
is evident from the work of Henderson and
McNeill (9), in which Lactobacillus plantarum
fatty acid biosynthesis is subject to feedback
regulation by exogenous long-chain fatty acids.
It is also implicit in work (16, 22) showing
pronounced changes in fatty acid and phos-
pholipid composition in response to changing
growth conditions; i.e., changes in tempera-
ture, oxygen tension, stage of growth cycle,
growth rate, or nutritional limitations of the
carbon or nitrogen supply.
Our finding that growth on limiting aspar-
tate forces the cells to produce four times as
much coenzyme A and acyl carrier protein as
normal is a further indication of fatty acid
biosynthetic control. The interdependence of
pantothenate and tricarboxylic acid-cycle com-
pounds is reasonable because the rate of fatty
acid synthesis is determined by the enzyme ac-
etyl coenzyme A carboxylase which converts
acetyl coenzyme A to malonyl coenzyme A
(27). This important enzyme is activated by
the di- and tricarboxylic acids of the tricar-
boxylic acid cycle, and in their absence very
little fatty acid is formed (27). Added aspartate
would then allow the fatty acid biosynthetic
machinery already present to function more
efficiently and so eliminate the need for addi-
tional machinery. This.is fundamentally differ-
ent from the observation of Maas and Davis
(21) that in Escherichia coli L-aspartate acts as
an inhibitor of pantothenate synthesis by com-
peting with j-alanine for the pantothenate
synthetase enzyme.
Holden and his colleagues (10-12) have
shown that an abnormally large amino acid
requirement may result from a leaky mem-
brane and the consequent inability of the
organism to maintain a sufficiently large pool
size. A selectivity must exist with regard to
which pools are susceptible to loss through a
leaky membrane. Obviously, the coenzyme A
pool is larger (Tables 2 and 3) under the
aspartate-limited conditions postulated to ac-
centuate leakiness. The aspartate pool is espe-
cially important because of its role in activat-
ing fatty acid synthesis. If its concentration
drops below a certain level, a vicious circle is
created. Aspartate is lost through a leaky
membrane because there is not enough aspar-
tate to provide adequate synthesis of fatty
acids. The pool of tricarboxylic acid cycle
intermediates may be especially sensitive to
loss through a leaky or defective membrane
because the enzymes responsible for their for-
mation are localized in that membrane.
The methionine auxotrophy already present
in strain WM-11 may be responsible for dif-
ferentiating WMP-1 from other pantothenate
auxotrophs which do not require aspartate.
Strain WM-11 is also stimulated by added
tricarboxylic acid cycle intermediates (Table
1). However, this stimulation is enhanced in
the pantothenate auxotroph WMP-1 to the
point where it is an absolute requirement. We
have already presented evidence (13) that
strain WM-11 differs from its parent strain W
in its mode of methylating cellular lipids. This
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acids. A somewhat different specificity of
membrane methylation patterns could explain
the greater susceptibility to membrane leakage
in both WM-11 and WMP-11. One possible
cause of this difference in methylation would
involve the known ability (17) of excess methio-
nine to repress its own synthesis by repression
of 5, 10-methylenefolate-H, reductase. This
enzyme converts 5, 10-methylenefolate-H4 to
5-methylfolate-H4, the immediate precursor of
the methionine methyl group. The amounts of
methionine added to our methionine auxo-
trophs should be sufficient to repress the reduc-
tase, thus totally eliminating 5-methylfolate-
H4 production. If the 5-methylfolate-H4 had an
independent role in lipid methylation, that role
would be lost, and the methionine auxotrophs
would have to rely exclusively on the S-adeno-
syl methionine route to achieve methylation.
Postulating an alternative route for methyla-
tion does not conflict with previous work (14)
proving the existence of the S-adenosyl methio-
nine route.
We should at least mention a few other
possible reasons why strain WMP-1 requires
aspartate. The pantothenate lesion may cause
the metabolite immediately preceding the
block to accumulate. At an elevated concentra-
tion, this metabolite might become inhibitory
and require tricarboxylic acid cycle intermedi-
ates in excess to overcome that inhibition. The
only two candidates would be 2-keto isovaler-
ate and 2-keto pantoate. If true, the tricarboxy-
lic acid requirement should have been evident
in most other pantothenate auxotrophs with
defective pantoic acid synthesis.
Alternatively, the aspartate may have been
relieving a shortage in C4 intermediates caused
by a defective phosphoenolpyruvate carboxyl-
ase. Thls anaplerotic mechanism could be
defective either because of a biotin deficiency
(note the biotin stimulation in Table 1) or
because the phosphoenolpyruvate carboxylase
activator (4) acetyl coenzyme A is in short
supply. This is certainly a reasonable supposi-
tion in pantothenate-deficient organisms, as
Grula et al. (7) have pointed out, but this does
not explain our observation that coenzyme A
and acyl carrier protein levels decrease when
sufficient aspartate is added.
LITERATURE CITED
1. Alberts, A. W., and P. R. Vagelos. 1966. Acyl carrier
protein. VIII. Studies of acyl carrier protein and
coenzyme A in Escherichia coli pantothenate or al-ala-
nine auxotrophs. J. Biol. Chem. 241:5201-5204.
2. Britten, R. J., and F. T. McClure. 1962. The amino acid
pool in Escherichia coli. Bacteriol. Rev. 26:292-335.
3. Broquist, H. P., and E. E. Snell. 1951. Biotin and
bacterial growth. I. Relation to aspartate, oleate, and
carbon dioxide. J. Biol. Chem. 188:431-444.
4. Canovas, J. L., and H. L. Kornberg. 1965. Fine control of
phosphopyruvate carboxylase activity in Escherichia
coli. Biochim. Biophys. Acta 96:169-172.
5. Goldfine, H., and M. E. Ellis. 1964. N-Methyl groups in
bacterial lipids. J. Bacteriol. 87:8-15.
6. Greenspan, M. D., A. W. Alberts, and P. R. Vagelos.
1969. Acyl carrier protein. XIII. ,-Ketoacyl acyl car-
rier protein synthetase from Escherichia coli. J. Biol.
Chem. 244:6477-6485.
7. Grula, M. M., R. W. Smith, C. F. Parham, and E. A.
Grula. 1968. Cell division in a species of Erwinia. XI.
Some aspects of the carbon and nitrogen nutrition of
Erwinia species. Can. J. Microbiol. 14:1217-1225.
8. Guirard, B. M., and E. E. Snell. 1962. Nutritional
requirements of microorganisms, p. 33-93. In I. C.
Gunsalus and R. Y. Stanier (ed.), The bacteria, vol. 4.
Academic Press Inc., New York.
9. Henderson, T. O., and J. J. McNeill. 1966. The control of
fatty acid synthesis in Lactobacillus plantarum. Bio-
chem. Biophys. Res. Commun. 25:662-669.
10. Holden, J. T., and J. M. Bunch. 1972. Stimulation by
fatty acids of amino acid accumulation in pantothenic
acid depleted Lactobacillus plantarum. Biochem. Bio-
phys. Res. Commun. 46:437-442.
11. Holden, J. T., 0. Hild, Y. Wong-Leung, and G. Rouser.
1970. Reduced lipid content as the basis for defective
amino acid accumulation capacity in pantothenate-
and biotin-deficient Lactobacillus plantarum. Bio-
chem. Biophys. Res. Commun. 40:123-128.
12. Holden, J. T., and N. M. Utech. 1967. Effect of biotin,
pantothenic acid and nicotinic acid deficiencies on
amino acid transport in Lactobacillus plantarum.
Biochim. Biophys. Acta 135:517-531.
13. Kaneshiro, T. 1968. Methylation of the cellular lipid of
methionine-requiring Agrobacterium tumefaciens. J.
Bacteriol. 95:2078-2082.
14. Kaneshiro, T., and J. H. Law. 1964. Phosphatidylcholine
synthesis in Agrobacterium tumefaciens. I. Purificat-
ion and properties of a phosphatidylethanolamine
N-methyltransferase. J. Biol. Chem. 239:1705-1713.
15. Kaneshiro, T., and A. G. Manf. 1962. Phospholipids of
Azotobacter agilis, Agrobacterium tumefaciens, and
Escherichia coli. J. Lipid Res. 3:184-189.
16. Kates, M. 1964. Bacterial lipids. Advan. Lipid Res.
2:17-90.
17. Katzen, H. M., and J. M. Buchanan. 1965. Enzymatic
synthesis of the methyl group of methionine. VIII.
Repression-derepression, purification, and properties
of 5,10 methylenetetrahydrofolate reductase from
Escherichia coli. J. Biol. Chem. 240:825-835.
18. Law, J. H., H. Zalkin, and T. Kaneshiro. 1963. Trans-
methylation reactions in bacterial lipids. Biochim.
Biophys. Acta 70:143-151.
19. Lennarz, W. J. 1970. Bacterial lipids, p. 155-184. In S. J.
Wakil (ed.), Lipid metabolism. Academic Press Inc.,
New York.
20. Lowry, 0. H., N. J. Rosebrough, A. L. Farr, and R. J.
Randall. 1951. Protein measurement with the Folin
phenol reagent. J. Biol. Chem. 193:265-275.
21. Maas, W. K., and B. D. Davis. 1950. Pantothenate
studies. I. Interference by D-serine and L-aspartic acid
with pantothenate synthesis in Escherichia coli. J.
Bacteriol. 60:733-745.
22. Marr, A. G., and J. L. Ingraham. 1962. Effect of
temperature on the composition of fatty acids in
Escherichia coli. J. Bacteriol. 84:1260-1267.
23. Novelli, G. D. 1955. Pantothenate-synthesizing enzyme,
p. 619-622. In S. P. Colowick and N. 0. Kaplan (ed.),



























KANESHIRO, ARTHUR, AND NICKERSON
Methods in enzymology, vol. 2. Academic Pres Inc.,
New York.
24. Novelli, G. D., N. 0. Kaplan, and F. Lipmann. 1949.
The liberation of pantothenic acid from coenzyme A.
J. Biol. Chem. 177:97-107.
25. Novelli, G. D., and F. Lipmann. 1950. The catalytic
function ofcoenzyme A in citric acid synthesis. J. Biol.
Chem. 182:213-228.
26. Powell, G. L., J. Elovson, and P. R. Vagelos. 1969. Acyl
carrier protein. XI. Synthesis and turnover of the
prosthetic group of acyl carrier protein in vivo. J. Biol.
Chem. 24:5616-5624.
27. Reeves, H. C., R. Rabin, W. S. Wegener, and S. J. Aji.
1967. Fatty acid synthesis and metabolism in microor-
ganisms. Annu. Rev. Microbiol. 21:225-256.
28. Stadtman, E. R. 1966. Allosteric regulation of enzyme
activity. Advan. Enzymol. 28:41-154.
29. Toennies, G., D. N. Das, and F. Feng. 1966. Pantothe-
nate and coenzyme A in bacterial growth. J. Bacteriol.
92:707-713.




















ber 5, 2007 
jb.asm
.org
D
ow
nloaded from
 
